|
Getting your Trinity Audio player ready...
|
Grains are particularly problematic for people with insulin resistance and high blood pressure for several interconnected reasons:
The Glucose-Insulin Cascade
All grains—even whole grains—are predominantly starch, which breaks down rapidly into glucose. For someone with insulin resistance, their cells don’t respond properly to insulin’s signal to absorb glucose. The pancreas compensates by producing even more insulin, creating chronically elevated insulin levels (hyper-insulinemia). This excess insulin directly raises blood pressure through multiple mechanisms: it increases sodium retention in the kidneys, activates the sympathetic nervous system, and promotes arterial stiffness.
The Whole Grain Myth
While whole grains digest slightly slower than refined grains due to their fibre content, they still cause substantial blood sugar spikes. A bowl of whole grain oatmeal or brown rice will raise blood glucose similarly to white rice—just over a slightly longer timeframe. For someone already struggling with insulin resistance, this repeated glucose bombardment throughout the day (breakfast cereal, sandwich at lunch, pasta at dinner) never allows insulin levels to drop, perpetuating the cycle.
Inflammatory Components
Beyond the starch, grains contain several compounds that can worsen metabolic dysfunction:
1. Lectins and phytates: These can damage the intestinal lining, increasing intestinal permeability
2. Gluten proteins: Gluten (in wheat, barley and rye to name a few) that trigger inflammation even in non-celiacs when the gut barrier is compromised
3. Omega-6 fatty acids: These promote inflammatory pathways when consumed in excess
This is particularly relevant given that gliadin from grains activates the zonulin pathway (which leads to tight junction breakdown in the gut) and endotoxin absorption, worsening insulin resistance through chronic inflammation.
The Vascular Impact
The combination of hyper-insulinemia and chronic inflammation from grain consumption directly damages the endothelium (blood vessel lining), reduces nitric oxide production needed for vessel dilation, and promotes arterial plaque formation. For someone with both insulin resistance and hypertension, grains essentially fuel both conditions simultaneously.
Research Studies Supporting Grains and Insulin Resistance Claims
Concise Reference List
KEY TAKEAWAY
Total Studies: 15 peer-reviewed studies
Strong Evidence (12 studies):
• Grain glucose/insulin response: 3 studies
• Hyper-insulinemia → hypertension: 3 studies
• Grains → intestinal permeability: 5 studies
• Gut permeability → insulin resistance: 2 studies
Complex/Revised Evidence (3 studies):
• Omega-6 and inflammation: 3 studies showing conflicting results
Bottom Line: All claims are well-supported EXCEPT the omega-6 inflammation claim, which should be revised to focus on the omega-6:omega-3 RATIO (20:1 in Western diet) rather than stating omega-6 is inherently inflammatory. Recent 2025 evidence suggests omega-6 may actually be anti-inflammatory when not consumed in extreme ratios.
SECTION 1: GLUCOSE-INSULIN CASCADE FROM GRAINS
Study 1.1
Title: Effect of Brown Rice, White Rice, and Brown Rice with Legumes on Blood Glucose and Insulin Responses in Overweight Asian Indians: A Randomised Controlled Trial
Date: April 2014
Organization: St. John’s Research Institute, Bangalore, India
URL: https://pubmed.ncbi.nlm.nih.gov/24456394/
Summary: This randomized controlled trial of 15 overweight Asian Indian adults found that while brown rice reduced fasting insulin by 57% compared to white rice over 5 days, brown rice still generated substantial insulin responses and had a glycemic index ranging from 50-87 depending on variety and processing. The study demonstrates that brown rice, though better than white rice, still triggers significant insulin secretion in overweight individuals.
Study 1.2
Title: The effects of whole-grain compared with refined wheat, rice, and rye on the postprandial blood glucose response: a systematic review and meta-analysis of randomised controlled trials
Date: November 2018
Organization: PepsiCo R&D and University of Toronto, Canada
URL: https://pubmed.ncbi.nlm.nih.gov/30321274/
Summary: This systematic review and meta-analysis of 20 publications found that ground wholemeal wheat was NOT associated with significant reduction in blood glucose area under the curve compared to white wheat. Whole-grain rice did significantly attenuate postprandial blood glucose response compared to white rice, but processing (grinding/milling) eliminates most glucose benefits even in whole grains.
Study 1.3
Title: The effect of a brown-rice diets on glycemic control and metabolic parameters in pre-diabetes and type 2 diabetes mellitus: a meta-analysis of randomized controlled trials and controlled clinical trials
Date: May 26, 2021
Organization: Universitas Padjadjaran, Indonesia
URL: https://pubmed.ncbi.nlm.nih.gov/34123581/
Summary: This meta-analysis of 7 trials involving 417 adults with prediabetes or type 2 diabetes found that brown rice consumption showed NO effect on HbA1c levels (p=0.15) and NO effect on fasting blood glucose (p=0.95) compared to white rice. While brown rice reduced body weight by 2.2 kg, it did not improve glycemic control in diabetic or pre-diabetic patients.
SECTION 2: HYPERINSULINEMIA CAUSES HYPERTENSION
Study 2.1
Title: ROLE OF HYPERINSULINEMIA AND INSULIN RESISTANCE IN HYPERTENSION: METABOLIC SYNDROME REVISITED
Date: May 2020
Organization: University of Mississippi Medical Center, USA
URL: https://pubmed.ncbi.nlm.nih.gov/32389340/
Summary: This comprehensive review examined 30+ years of research on hyperinsulinemia and hypertension, confirming that short-term studies showed hyperinsulinemia increases sympathetic nervous system activity and renal sodium retention. The metabolic effects of insulin resistance (hyperglycemia, dyslipidemia) interact synergistically with increased blood pressure to cause vascular and kidney injury that exacerbates hypertension.
Study 2.2
Title: Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension
Date: August 2010
Organisation: Baker IDI Heart and Diabetes Institute, Melbourne, Australia
URL: https://pubmed.ncbi.nlm.nih.gov/20444953/
Summary: This study of lean essential hypertensive patients found that salt sensitivity of blood pressure is strongly associated with insulin resistance. The glucose infusion rate (measure of insulin sensitivity) inversely correlated with changes in urinary sodium excretion, hematocrit (fluid retention), and urinary norepinephrine (sympathetic activation), demonstrating that hyperinsulinemia, sympathetic overactivation, and reduced suppression of the renin-angiotensin system all contribute to salt-sensitive hypertension.
Study 2.3
Title: Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension
Date: April 1992
Organization: Federico II University, Naples, Italy
URL: https://pubmed.ncbi.nlm.nih.gov/1634611/
Summary: This study demonstrated that hyperinsulinemia evoked a threefold greater increase in forearm norepinephrine release in hypertensive patients compared to normotensive subjects (2.28 vs 0.80 ng/L/min, P<0.01). The research proved that insulin evokes abnormal muscle sympathetic overactivity in essential hypertension mediated by mechanisms involving the central nervous system.
SECTION 3: GRAINS DAMAGE INTESTINAL BARRIER
Study 3.1
Title: Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines
Date: April 2006
Organization: University of Maryland School of Medicine, USA
URL: https://pubmed.ncbi.nlm.nih.gov/16635908/
Summary: This landmark study demonstrated that gliadin activates zonulin signalling irrespective of genetic expression of autoimmunity, leading to increased intestinal permeability in both celiac and non-celiac patients. When exposed to gliadin, both celiac patients and non-celiac controls showed zonulin release, cytoskeletal rearrangement, and loss of tight junction proteins, though the magnitude was greater in celiac patients.
Study 3.2
Title: The Dietary Intake of Wheat and other Cereal Grains and Their Role in Inflammation
Date: March 12, 2013
Organization: VU University Medical Center, Amsterdam, Netherlands
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC3705319/
Summary: This comprehensive review demonstrated that both gliadin from wheat gluten and wheat germ agglutinin (WGA) lectin increase intestinal permeability and activate the immune system in both in vitro and in vivo studies. The research concluded that consumption of wheat and other cereal grains can contribute to chronic inflammation and autoimmune diseases by increasing intestinal permeability and initiating pro-inflammatory immune responses.
Study 3.3
Title: Zonulin as a Biomarker for the Development of Celiac Disease
Date: January 2024
Organization: Massachusetts General Hospital and Harvard Medical School, USA
URL: https://publications.aap.org/pediatrics/article/153/1/e2023063050/196182/
Summary: This prospective birth cohort study of 102 at-risk children found that zonulin levels significantly rise in the months that precede celiac disease autoimmunity diagnosis, proving that increased intestinal permeability precedes disease onset. Exposure to multiple antibiotic courses was associated with increased zonulin levels in children who developed celiac disease autoimmunity, suggesting zonulin may be used as a biomarker for preclinical screening.
Study 3.4
Title: Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer
Date: January 2011
Organization: University of Maryland School of Medicine, USA (Alessio Fasano, MD)
URL: https://journals.physiology.org/doi/full/10.1152/physrev.00003.2008
Summary: This landmark review established zonulin as the only known physiological modulator of intercellular tight junctions and identified the two most powerful triggers for zonulin release: bacterial overgrowth and gluten (gliadin). Gliadin triggers zonulin release through the CXCR3 receptor via MyD88 signalling, suggesting that gluten is misinterpreted by the zonulin pathway as a harmful component of a microorganism.
Study 3.5
Title: All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases
Date: January 31, 2020
Organization: Massachusetts General Hospital and Harvard Medical School, USA (Alessio Fasano, MD)
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6996528/
Summary: This review confirmed that gliadin triggers zonulin release through CXCR3 receptor activation in a MyD88-dependent manner, leading to increased gut permeability by disassembly of tight junction protein ZO-1. Even healthy individuals show zonulin response to gluten (though less than celiac patients), and the zonulin inhibitor larazotide acetate has shown therapeutic efficacy in clinical trials for preventing gluten-dependent inflammation.
SECTION 4: OMEGA-6 AND INFLAMMATION (COMPLEX EVIDENCE)
Study 4.1
Title: Red Blood Cell Omega-6 Fatty Acids and Biomarkers of Inflammation in the Framingham Offspring Study
Date: January 2025
Organization: Framingham Heart Study / Fatty Acid Research Institute, USA
URL: https://www.mdpi.com/2072-6643/17/13/2076
Summary: This cross-sectional study of 2,700 individuals found that higher linoleic acid (LA) and arachidonic acid (AA) levels were associated with significantly lower levels of 5 out of 10 inflammatory biomarkers, with NO cases where higher omega-6 related to higher inflammation. The findings are exactly opposite of what would be expected if omega-6 fatty acids were pro-inflammatory, suggesting they may actually be anti-inflammatory.
Study 4.2
Title: The Importance of Maintaining a Low Omega-6/Omega-3 Ratio for Reducing the Risk of Autoimmune Diseases, Asthma, and Allergies
Date: October 4, 2021
Organization: Independent Review
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8504498/
Summary: This review documented that the Western diet now provides an omega-6:omega-3 ratio of approximately 20:1 (versus 4:1 historically), which may predispose to chronic inflammatory conditions. In inflammatory bowel disease patients specifically, linoleic acid caused a nine-fold increase in IL-8 secretion and activated arachidonic acid pathways, increasing pro-inflammatory metabolites, suggesting the RATIO of omega-6 to omega-3 matters more than absolute amounts.
Study 4.3
Title: Omega-6 fatty acids and inflammation
Date: May 2018
Organization: University of Southampton, UK
URL: https://pubmed.ncbi.nlm.nih.gov/29610056/
Summary: This review found that studies in healthy human adults showed increased intake of arachidonic acid (ARA) or linoleic acid (LA) does NOT increase concentrations of many inflammatory markers, and epidemiological studies even suggested they may be linked to reduced inflammation. However, high omega-6 diets may inhibit the anti-inflammatory and inflammation-resolving effects of omega-3 fatty acids, indicating the interaction is complex and not fully understood.
SECTION 5: GUT PERMEABILITY LINKED TO INSULIN RESISTANCE
Study 5.1
Title: Circulating Zonulin, a Marker of Intestinal Permeability, Is Increased in Association with Obesity-Associated Insulin Resistance
Date: May 18, 2012
Organization: Hospital Universitari Dr. Josep Trueta, Girona, Spain
URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0037160
Summary: This study of 123 men demonstrated that circulating zonulin levels independently correlate with insulin resistance even after controlling for body weight and other metabolic factors (p=0.002). The relationship between zonulin and insulin resistance is mediated through IL-6 (a key inflammatory cytokine), making this the first study to establish a direct link between metabolic dysfunction and intestinal barrier integrity.
Study 5.2
Title: Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients
Date: September 6, 2014
Organization: Shanghai Jiao Tong University, China
URL: https://www.sciencedirect.com/science/article/abs/pii/S0168822714003805
Summary: This study of 388 Chinese adults confirmed that zonulin levels are significantly elevated before Type 2 diabetes develops and are independently associated with insulin resistance (β=0.024, p=0.005). Zonulin emerged as an independent predictor of diabetes (OR=1.080, p=0.037) and correlated with multiple markers of metabolic dysfunction including triglycerides, inflammatory cytokines, and HOMA-IR, reinforcing the central role of gut permeability in metabolic disease.